FinanceAsianet Newsable
HIMS Stock Rises 13% on FDA Panel BPC-157 Recommendation
in5points
An FDA advisory panel recommended adding the peptide BPC-157 to a list that allows compounding pharmacies to prepare it more freely for patients.
The recommendation came on Thursday from the FDA panel.
HIMS stock rallied 13% in response to the news.
Story angle
Center-right
L
CL
C
CR
R
Mostly straight facts, with a light government- or market-friendly tilt.
About how the story is framed, not whether the facts are true.
Asianet Newsable
Center-right
Mixed factuality
Who owns this?
Asianet News Network
Rajeev Chandrasekhar / Jupiter Capital interests historically